ask="49.35"
ask_size="100"
average_daily_volume="1136980"
bid="30.00"
bid_size="100"
book_value="10.71"
change="-0.91"
change_from_200_day_moving_average="-4.91"
change_from_50_day_moving_average="4.05"
change_from_52_week_high="-34.16"
change_From_52_week_low="14.57"
change_in_percent="-1.94%"
close="45.95"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.79"
ebitda="-409.46M"
eps_estimate_current_year="-5.09"
eps_estimate_next_quarter="-1.30"
eps_estimate_next_year="-4.74"
ex_dividend_date="N/A"
float_shares="71056000"
high="47.32"
high_52_weeks="80.11"
last_trade_date="2/22/2017"
last_trade_price="45.95"
last_trade_size="60202"
last_trade_time="4:00pm"
low="45.68"
low_52_weeks="31.38"
market_capitalization="3.95B"
moving_average_200_day="50.86"
moving_average_50_day="41.90"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="62.73"
open="46.79"
pe_ratio="N/A"
peg_ratio="-0.21"
percent_change_from_200_day_moving_average="-9.65%"
percent_change_from_50_day_moving_average="+9.68%"
percent_change_from_52_week_high="-42.64%"
percent_change_from_52_week_low="+46.43%"
previous_close="46.86"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.38"
price_per_sales="85.47"
revenue="47.16M"
shares_outstanding="86013000"
short_ratio="10.08"
stock_exchange="NMS"
symbol="ALNY"
volume="632121"
weeks_range_52="31.38 - 80.11"
